Livzon Pharmaceutical Group Inc: freeze-dried varicella inactivated vaccine was granted clinical trial approval notification.

Chengdu Brilliant Bio announced that the freeze-dried varicella inactivated vaccine developed by its wholly-owned subsidiary, Anhui Brilliant Dragon Kama Biopharmaceutical Co., Ltd., has obtained the notice of approval for drug clinical trial from the National Medical Products Administration, allowing the initiation of clinical trials for the prevention of varicella caused by varicella-zoster virus infection.